| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | 2,703,471 | CAI, HNGE, GKOS, EWTX | 13F-HR | 8/14/2026 | 000142050626001823 |
| Q1 2026 | 88 | 2,997,744 | CAI, GUARDANT HEALTH INC, REPLIGEN CORP, NEOGENOMICS INC | 13F-HR | 5/15/2026 | 000142050626001145 |
| Q4 2025 | 73 | 3,126,999 | CAI, GUARDANT HEALTH INC, EWTX, REPLIGEN CORP | 13F-HR | 2/17/2026 | 000142050626000586 |
| Q3 2025 | 73 | 3,370,348 | GUARDANT HEALTH INC, CAI, NOVOCURE LTD, XENE | 13F-HR | 11/14/2025 | 000142050625003410 |
| Q2 2025 | 55 | 2,923,924 | GUARDANT HEALTH INC, CAI, NBIX, NOVOCURE LTD | 13F-HR | 8/14/2025 | 000142050625002183 |
| Q1 2025 | 64 | 2,844,802 | GUARDANT HEALTH INC, NOVOCURE LTD, NBIX, BRIDGEBIO PHARMA INC | 13F-HR | 5/15/2025 | 000142050625001293 |
| Q4 2024 | 73 | 3,372,652 | GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, NBIX | 13F-HR | 2/14/2025 | 000192093825000002 |
| Q3 2024 | 81 | 3,527,985 | GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, DEXCOM INC, NOVOCURE LTD | 13F-HR | 11/14/2024 | 000192093824000006 |
| Q2 2024 | 75 | 3,187,767 | GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, DEXCOM INC, NOVOCURE LTD | 13F-HR | 8/14/2024 | 000142050624001566 |
| Q1 2024 | 70 | 3,102,773 | BRIDGEBIO PHARMA INC, GUARDANT HEALTH INC, EXACT SCIENCES CORP, NOVOCURE LTD | 13F-HR | 5/15/2024 | 000192093824000004 |
| Q4 2023 | 72 | 2,722,670 | BRIDGEBIO PHARMA INC, GUARDANT HEALTH INC, ASCENDIS PHARMA A/S, EXACT SCIENCES CORP | 13F-HR | 2/14/2024 | 000142050624000478 |
| Q3 2023 | 86 | 3,164,360 | GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, ASCENDIS PHARMA A/S | 13F-HR | 11/14/2023 | 000142050623002213 |
| Q2 2023 | 81 | 3,060,428 | GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, EXACT SCIENCES CORP, NOVOCURE LTD | 13F-HR | 8/14/2023 | 000142050623001695 |
| Q1 2023 | 81 | 3,032,008 | GUARDANT HEALTH INC, EXACT SCIENCES CORP, BRIDGEBIO PHARMA INC, NANOSTRING TECHNOLOGIES INC | 13F-HR | 5/15/2023 | 000090514823000454 |
| Q4 2022 | 88 | 2,984,124 | GUARDANT HEALTH INC, EXACT SCIENCES CORP, NANOSTRING TECHNOLOGIES INC, NOVOCURE LTD | 13F-HR | 2/14/2023 | 000142050623000696 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G.
3 securities where the latest filing since 12/18/2024 is a 13G, the newest filed 8/14/2026. View all